Upload
swapnil-hiremath
View
203
Download
5
Tags:
Embed Size (px)
Citation preview
May 28 – 30, 2015, Montréal, Québec
Contrast Nephropathy
Swapnil Hiremath, MD, MPH@hswapnilNephrologist
The Ottawa HospitalUniversity of Ottawa
Ottawa Hospital Research Institute
May 28 – 30, 2015, Montréal, Québec
Disclosure Statement: With a Conflict of Interest
Financial:
• Study funding: GE Healthcare is funding an economic analysis to study the impact of osmolality of contrast medium and acute kidney injury
• I own no stock or securities nor do I serve or have served as a consultant for any drug or device manufacturer
Others:
• I am the PI of an ongoing trial examining oral hydration (vs IV) to prevent contrast nephropathy
• I am a co-author of the Canadian Association of Radiology (CAR) guidelines
CAMRT joint Congress May 2015
Objectives
At the end of this talk, the listener will
• Identify patients who are at high risk of contrast nephropathy
• Know what to order to minimize risk of contrast nephropathy
CAMRT joint Congress May 2015
What is Contrast Nephropathy*?
*Now known as Contrast-induced
Acute Kidney Injury
Following Contrast exposure:
Arterial (cardiac cath, arteriograms)
Venous (CT Scans)
CAMRT joint Congress May 2015
What is Contrast Nephropathy*?
• Acute Kidney Injury, defined as:
• Rise in creatinine of 25%
• Rise in creatinine of 44 micromol/L
• A much smaller proportion: Dialysis or Death
*Now known as Contrast-induced
Acute Kidney Injury
Following Contrast exposure:
Arterial (cardiac cath, arteriograms)
Venous (CT Scans)
CAMRT joint Congress May 2015
Case• 59 year old gentleman, DM2
• Worsening angina
• Cr 170 at baseline (eGFR 38)
CAMRT joint Congress May 2015
Case• 59 year old gentleman, DM2
• Worsening angina
• Cr 170 at baseline (eGFR 38)
CAMRT joint Congress May 2015
Case• 59 year old gentleman, DM2
• Worsening angina
• Cr 170 at baseline (eGFR 38)
CAMRT joint Congress May 2015
Which patients are at risk?
• Arterial contrast (Cardiac Catheterization, Angiograms) >> Venous Contrast (Contrast enhanced CT scans)
CAMRT joint Congress May 2015
Which patients are at risk?
• Arterial contrast (Cardiac Catheterization, Angiograms) >> Venous Contrast (Contrast enhanced CT scans)
• Diabetes, Dehydration
CAMRT joint Congress May 2015
Which patients are at risk?
• Arterial contrast (Cardiac Catheterization, Angiograms) >> Venous Contrast (Contrast enhanced CT scans)
• Diabetes, Dehydration
• Severe Chronic Kidney Disease (eGFR < 30, stage 4 and 5 CKD)
CAMRT joint Congress May 2015
How should we prevent Contrast - AKI?Literature Roundup
>8000 publications
14 + 57 + 22 + 18=113 RCTs
(4 interventions)
3412 with RCT filter
42 Meta-analyses
CAMRT joint Congress May 2015
How should we prevent Contrast - AKI?Literature Roundup
>8000 publications
14 + 57 + 22 + 18=113 RCTs
(4 interventions)
3412 with RCT filter
42 Meta-analyses
+ 82 studies currently recruiting
(per Clinicaltrials.gov)
CAMRT joint Congress May 2015
N-Acetyl Cysteine: Definitive Evidence
ACT study, Berwanger et al, Circulation, 2011
N = 2272
CAMRT joint Congress May 2015
N-Acetyl Cysteine: Definitive Evidence
ACT study, Berwanger et al, Circulation, 2011
N = 2272
CAMRT joint Congress May 2015
Oral hydration?
Source: Hiremath et al, PLoS One, 2013Small number of studiesOngoing trial at Ottawa
CAMRT joint Congress May 2015
Safer Contrast MediaIonicity Relative
OsmolalityOsmolality (mOsm/kg H20)
Examples
Ionic monomers High osmolality 1500 – 1900 Diatrizoate, Iothalamate, Metrizoate, Iodamide, Ioxithalamate
Ionic dimers Low osmolality 600 IoxaglateNonionic monomers Low osmolality 500 – 700 Iopamidol,
Iohexol,Iomeprol,Iopentol,Iopromide,Ioversol,Ioxitol,Metrizamide
Nonionic dimers Iso-osmolal 290-320 Iodixanol,Iotrolan
CAMRT joint Congress May 2015
Safer Contrast MediaIonicity Relative
OsmolalityOsmolality (mOsm/kg H20)
Examples
Ionic monomers High osmolality 1500 – 1900 Diatrizoate, Iothalamate, Metrizoate, Iodamide, Ioxithalamate
Ionic dimers Low osmolality 600 IoxaglateNonionic monomers Low osmolality 500 – 700 Iopamidol,
Iohexol,Iomeprol,Iopentol,Iopromide,Ioversol,Ioxitol,Metrizamide
Nonionic dimers Iso-osmolal 290-320 Iodixanol,Iotrolan
CAMRT joint Congress May 2015
Safer Contrast MediaIonicity Relative
OsmolalityOsmolality (mOsm/kg H20)
Examples
Ionic monomers High osmolality 1500 – 1900 Diatrizoate, Iothalamate, Metrizoate, Iodamide, Ioxithalamate
Ionic dimers Low osmolality 600 IoxaglateNonionic monomers Low osmolality 500 – 700 Iopamidol,
Iohexol,Iomeprol,Iopentol,Iopromide,Ioversol,Ioxitol,Metrizamide
Nonionic dimers Iso-osmolal 290-320 Iodixanol,Iotrolan
CAMRT joint Congress May 2015
Safer Contrast MediaIonicity Relative
OsmolalityOsmolality (mOsm/kg H20)
Examples
Ionic monomers High osmolality 1500 – 1900 Diatrizoate, Iothalamate, Metrizoate, Iodamide, Ioxithalamate
Ionic dimers Low osmolality 600 IoxaglateNonionic monomers Low osmolality 500 – 700 Iopamidol,
Iohexol,Iomeprol,Iopentol,Iopromide,Ioversol,Ioxitol,Metrizamide
Nonionic dimers Iso-osmolal 290-320 Iodixanol,Iotrolan
CAMRT joint Congress May 2015
Safer Contrast MediaIonicity Relative
OsmolalityOsmolality (mOsm/kg H20)
Examples
Ionic monomers High osmolality 1500 – 1900 Diatrizoate, Iothalamate, Metrizoate, Iodamide, Ioxithalamate
Ionic dimers Low osmolality 600 IoxaglateNonionic monomers Low osmolality 500 – 700 Iopamidol,
Iohexol,Iomeprol,Iopentol,Iopromide,Ioversol,Ioxitol,Metrizamide
Nonionic dimers Iso-osmolal 290-320 Iodixanol,Iotrolan
CAMRT joint Congress May 2015
Safer Contrast Media
• Low Osmolar >>safer then High Osmolar (Barrett et al, Radiology 1993)
Ionicity Relative Osmolality
Osmolality (mOsm/kg H20)
Examples
Ionic monomers High osmolality 1500 – 1900 Diatrizoate, Iothalamate, Metrizoate, Iodamide, Ioxithalamate
Ionic dimers Low osmolality 600 IoxaglateNonionic monomers Low osmolality 500 – 700 Iopamidol,
Iohexol,Iomeprol,Iopentol,Iopromide,Ioversol,Ioxitol,Metrizamide
Nonionic dimers Iso-osmolal 290-320 Iodixanol,Iotrolan
CAMRT joint Congress May 2015
Safer Contrast Media
• Low Osmolar >>safer then High Osmolar (Barrett et al, Radiology 1993)
• Iso-osmolar versus Low osmolar?
Ionicity Relative Osmolality
Osmolality (mOsm/kg H20)
Examples
Ionic monomers High osmolality 1500 – 1900 Diatrizoate, Iothalamate, Metrizoate, Iodamide, Ioxithalamate
Ionic dimers Low osmolality 600 IoxaglateNonionic monomers Low osmolality 500 – 700 Iopamidol,
Iohexol,Iomeprol,Iopentol,Iopromide,Ioversol,Ioxitol,Metrizamide
Nonionic dimers Iso-osmolal 290-320 Iodixanol,Iotrolan
CAMRT joint Congress May 2015
Is Iodixanol truly superior?
CARE study, Solomon et al, Circulation, 2007
N = 414
CAMRT joint Congress May 2015
What about Dialysis to remove contrast?
Marenzi et al, New Engl J Med, 2003
N = 114
Cruz et al, AJKD, 2007
CAMRT joint Congress May 2015
What about Dialysis to remove contrast?
Reinecke et al, Clin Res Cardiol, 2007
CAMRT joint Congress May 2015
Comparison of Effect Sizes
Intervention First Study Best Study
N-Acetyl Cysteine 0.1 1.01
Bicarb-based Hydration 0.125 0.94
Dialysis after Contrast 0.1 0.90
Iso-osmolar vs low-osmolar Contrast
0.09 1.13
CAMRT joint Congress May 2015
Comparison of Effect Sizes
Intervention First Study Best Study
N-Acetyl Cysteine 0.1 1.01
Bicarb-based Hydration 0.125 0.94
Dialysis after Contrast 0.1 0.90
Iso-osmolar vs low-osmolar Contrast
0.09 1.13
CAMRT joint Congress May 2015
Comparison of Effect Sizes
Intervention First Study Best Study
N-Acetyl Cysteine 0.1 1.01
Bicarb-based Hydration 0.125 0.94
Dialysis after Contrast 0.1 0.90
Iso-osmolar vs low-osmolar Contrast
0.09 1.13
CAMRT joint Congress May 2015
Comparison of Effect SizesIntervention
First Study
Best Study
N-Acetyl Cysteine 0.1
NEJM1.01
CirculationN-Acetyl Cysteine 0.1
N = 831.01
N =2400
Bicarb-based Hydration 0.125
JAMA0.94
JAMABicarb-based Hydration 0.125
N =1190.94
N = 353
Dialysis after Contrast 0.1
NEJM0.90
CRCDialysis after Contrast 0.1
N = 1140.90
N = 424
Iso-osmolar Contrast 0.09
NEJM1.13
JACCIso-osmolar Contrast 0.09
N = 1291.13
N = 418
CAMRT joint Congress May 2015
Contrast media Acute Kidney Injury
Does Venous Contrast cause Acute Kidney
Injury?
CAMRT joint Congress May 2015
Contrast media Acute Kidney Injury
Does Venous Contrast cause Acute Kidney
Injury?
CAMRT joint Congress May 2015
Contrast media Acute Kidney Injury
SepsisCardiogenic Shock
Does Venous Contrast cause Acute Kidney
Injury?
CAMRT joint Congress May 2015
Contrast media Acute Kidney Injury
SepsisCardiogenic Shock
Does Venous Contrast cause Acute Kidney
Injury?
CAMRT joint Congress May 2015
Contrast-induced
Contrast media Acute Kidney Injury
SepsisCardiogenic Shock
Does Venous Contrast cause Acute Kidney
Injury?
CAMRT joint Congress May 2015
Contrast-associated
Contrast media Acute Kidney Injury
SepsisCardiogenic Shock
Does Venous Contrast cause Acute Kidney
Injury?
CAMRT joint Congress May 2015
Others
• If hydration helps, so will stopping diuretics
• Potentially nephrotoxic medications: NSAIDs, others
• RAS Blockade? (ACE inhibitors, Angiotensin receptor blockers, renin inhibitors, spironolactone)
• Statins
CAMRT joint Congress May 2015
Metformin and Contrast?• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned for causing lactic acidosis. Case reports exist with metformin as well
CAMRT joint Congress May 2015
Metformin and Contrast?• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned for causing lactic acidosis. Case reports exist with metformin as well
• So, if a patient is on metformin AND
CAMRT joint Congress May 2015
Metformin and Contrast?• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned for causing lactic acidosis. Case reports exist with metformin as well
• So, if a patient is on metformin AND
• Is given contrast AND
CAMRT joint Congress May 2015
Metformin and Contrast?• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned for causing lactic acidosis. Case reports exist with metformin as well
• So, if a patient is on metformin AND
• Is given contrast AND
• Develops severe AKI (GFR <20) AND
CAMRT joint Congress May 2015
Metformin and Contrast?• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned for causing lactic acidosis. Case reports exist with metformin as well
• So, if a patient is on metformin AND
• Is given contrast AND
• Develops severe AKI (GFR <20) AND
• Metformin is not stopped THEN
CAMRT joint Congress May 2015
Metformin and Contrast?• Metformin is NOT nephrotoxic;
phenformin, its predecessor was banned for causing lactic acidosis. Case reports exist with metformin as well
• So, if a patient is on metformin AND
• Is given contrast AND
• Develops severe AKI (GFR <20) AND
• Metformin is not stopped THEN
• There is a possibility of lactic acidosis
CAMRT joint Congress May 2015
Metformin and Contrast?
‘ The legacy of phenformin, anecdotes, scattered case reports, product inserts and medicolegal anxieties are more at the heart of this issue than scientific fact’ - Gerald Pond, Radiology, 2001
CAMRT joint Congress May 2015
Summary• Contrast procedures have become safer with
time
• IV (eg CT scans) contrast is considerably less harmful than IA contrast (eg cardiac cath)
CAMRT joint Congress May 2015
Summary• Contrast procedures have become safer with
time
• IV (eg CT scans) contrast is considerably less harmful than IA contrast (eg cardiac cath)
• CKD stage 4 & 5 (GFR < 30) might still be at risk of AKI with CT Scans
CAMRT joint Congress May 2015
Summary• Contrast procedures have become safer with
time
• IV (eg CT scans) contrast is considerably less harmful than IA contrast (eg cardiac cath)
• CKD stage 4 & 5 (GFR < 30) might still be at risk of AKI with CT Scans
• Most prophylactic measures (bicarb, NAC, dialysis) don’t work; except for volume expansion
CAMRT joint Congress May 2015
Thank you
• Email: [email protected]
• Twitter: @hswapnil
• https://about.me/swapnil.hiremath